Area of research
Parasitology · Epidemiology
Research interest
Research interests include Parasites and Host Interactions, Trypanosoma species research and implications, Research on Leishmaniasis Studies, and SARS-CoV-2 and COVID-19 Research.
Vaccines and therapeutics for immunocompromised patients with COVID-19
The Lancet Commission on lessons for the future from the COVID-19 pandemic
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice
Identification of vaccine targets in pathogens and design of a vaccine using computational approaches
A yeast-expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates
The silent and dangerous inequity around access to COVID-19 testing: A call to action
Repeat-Driven Generation of Antigenic Diversity in a Major Human Pathogen, Trypanosoma cruzi
Urgent needs to accelerate the race for COVID-19 therapeutics
The SARS-CoV-2 Vaccine Pipeline: an Overview
Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention
COVID-19 vaccine design: the Janus face of immune enhancement
Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19
The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement
Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement
A scalable and reproducible manufacturing process for Phlebotomus papatasi salivary protein PpSP15, a vaccine candidate for leishmaniasis
Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America
A method to probe protein structure from UV absorbance spectra
Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen
Human Intestinal Parasite Burden and Poor Sanitation in Rural Alabama
Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate
Status of vaccine research and development of vaccines for leishmaniasis
The Global Economic and Health Burden of Human Hookworm Infection
The BENEFIT Trial: Where Do We Go from Here?
Advancing a vaccine to prevent human schistosomiasis
Neglected Tropical Diseases among the Association of Southeast Asian Nations (ASEAN): Overview and Update
Toxocariasis in North America: A Systematic Review
Global economic burden of Chagas disease: a computational simulation model
An Unfolding Tragedy of Chagas Disease in North America
New vaccines for neglected parasitic diseases and dengue
Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate